跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,327 条关于
“Traverse Biotech”
全部
5,327
临床试验
755
药物
781
机构
281
资讯
3,510
2年前
Traverse Biotech Receives NCI Grant to Develop Bispecific Antibody for Solid Tumors
去年
FDA Updates Testosterone Product Labels Following TRAVERSE Trial Safety Data
去年
FDA Removes Cardiovascular Black Box Warning from Testosterone Products Following TRAVERSE Trial Results
去年
Allogene's ALLO-316 Receives FDA RMAT Designation for Advanced Renal Cell Carcinoma
去年
ALLO-316 Granted RMAT Designation by FDA for Advanced Renal Cell Carcinoma
去年
Novel CAR T-Cell Therapy ALLO-316 Shows 33% Response Rate in Advanced Renal Cell Carcinoma
2个月前
Allogeneic CAR T-Cell Therapy ALLO-316 Demonstrates Durable Responses in Advanced Clear Cell Renal Cell Carcinoma
去年
ALLO-316 CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancer
去年
GenScript Biotech and NSG Bio Form Strategic Partnership to Accelerate Biotech Innovation in Singapore
2年前
Advances and Challenges in Renal Cell Carcinoma Treatment
第 1 页,共 351 页
上一页
下一页